« Back to Company News

FMCSA Accepts Comments on Commercial Driver Narcolepsy Exemption Requests

The Federal Motor Carrier Safety Administration is accepting comments through May 18 on applications from three drivers who are seeking an exemption from regulations that prohibit people with narcolepsy from operating a commercial motor vehicle (CMV) in interstate commerce.

The requests apply to a clinical diagnosis of a condition that is likely to cause a loss of consciousness or any loss of ability to operate a CMV safely, [49 CFR 391.41(b)(8)], or a mental, nervous, organic, or functional disease or psychiatric disorder likely to interfere with the ability to drive a commercial motor vehicle safely, [49 CFR391.41(b)(9)]. If granted, exemptions would allow the applicants, who are receiving medical treatment, to operate CMVs for two years in interstate commerce.

Narcolepsy is a disorder that involves poor control of sleep-wake cycles. It is treated with medications and behaviors such as maintaining a regular sleep schedule, routine exercise, and avoiding alcohol and tobacco consumption.

For information, refer to the April 17 Federal Register: www.gpo.gov/fdsys/pkg/FR-2015-04-17/pdf/2015-08857.pdf or the federal eRulemaking Portal: www.regulations.gov